Basic Trazodone Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In Canada (English): Desyrel; Oleptro (extended‑release tablets listed as US withdrawn, Canada); other international brands include Trittico and variants, Donaren, Trazolan, Trazone, Trazonil and regional trade names.
• ATC Code: N06AX05
• Forms & Dosages: Immediate‑release tablets commonly 50 mg and 100 mg; extended‑release or prolonged‑release tablets commonly 75 mg, 100 mg, 150 mg and formulations marked XR/CR/retard.
• Manufacturers In Canada (English): Major global suppliers include Angelini Group, Intas Pharma, Mylan and several generic manufacturers; local Canadian suppliers vary by brand and distributor.
• Registration Status In Canada (English): Registered and marketed in North America and many other regions for major depressive disorder; check product monographs and provincial listings for the most current status.
• OTC / Rx Classification: Prescription only (Rx).

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

Are clinicians still choosing trazodone for sleep or depression?

Recent systematic reviews and large pharmacoepidemiology cohorts from 2022 to 2025 reaffirm trazodone’s continuing role as a sedating antidepressant.

Those reviews quantify growing off‑label insomnia prescribing, particularly in older adults, and show rises in low‑dose nighttime use in primary care and community psychiatry settings.

Regulatory agencies including the FDA and EMA continue to list trazodone for major depressive disorder, and Health Canada classifies trazodone products as prescription‑only.

Common product names in circulation include Desyrel and Trittico variants among others.

Main Outcomes

What benefits did trials demonstrate?

Randomized trials show antidepressant efficacy comparable to older agents for moderate depression at therapeutic doses.

Low doses used at night consistently improved sleep continuity in short‑term trials, though long‑term randomized controlled trial support for insomnia is lacking.

Safety Observations

What safety signals emerged recently?

Post‑market and pharmacoepidemiology reports from 2022–2025 emphasise orthostatic hypotension and hyponatraemia in seniors, with rare reports of priapism.

Surveillance recommends careful dose titration in hepatic or renal impairment and monitoring in older patients at fall risk.

Clinical Mechanism Of Action

Layman’s Explanation

How does trazodone help mood and sleep?

Trazodone is an antidepressant that increases serotonin availability and blocks specific serotonin receptors to reduce anxiety and improve sleep.

At lower doses commonly used for sleep, sedation is the dominant effect.

Scientific Breakdown

What is happening at the receptor level?

Pharmacodynamically, trazodone combines serotonin reuptake inhibition with antagonism at 5‑HT2A and 5‑HT2C receptors.

Weaker antagonism at histamine H1 and alpha‑1 adrenergic receptors explains sedative properties and orthostatic effects.

Metabolism

How is trazodone processed by the body?

Trazodone is primarily metabolized hepatically via CYP isoenzymes, and dose adjustment is advised in liver disease to avoid accumulation.

Formulation Impact

Do different formulations matter?

Immediate‑release versus extended‑release formulations change peak concentrations and tolerability, with extended‑release products often improving adherence and lowering peak‑related side effects.

Examples of prolonged‑release products include Trittico retard and XR formulations.

Evidence and monographs recommend watching for interactions with other serotonergic agents.

Scope Of Approved & Off-Label Use

Health Canada Approvals (DIN-Based)

Is trazodone approved in Canada and what for?

Health Canada classifies trazodone as prescription‑only and marketed products are registered for major depressive disorder.

Brand names such as Desyrel and some extended‑release preparations are known internationally; check provincial formularies and product monographs for DIN specifics and Health Canada labelling.

Notable Off‑Label Trends In Canadian Practice

Why do prescribers use trazodone for sleep?

Off‑label low‑dose nocturnal prescribing for insomnia is common across provinces, with typical bedtime doses of 25–100 mg despite limited regulatory indication for insomnia.

Family physicians and psychiatrists frequently initiate these low‑dose regimens, and higher prescribing is seen in older adults where access to CBT‑I or sleep clinics may be limited.

Clinicians should reconcile off‑label use with evidence and consider provincial drug benefit coverage such as ODB, BC PharmaCare or RAMQ when planning treatment.

Dosage Strategy

General Dosing Per Health Canada Monographs

What dose should be started for depression or sleep?

For major depressive disorder, usual starting antidepressant doses are 75–150 mg per day in divided doses, with adult maxima commonly up to 400 mg per day and inpatient reports up to 600 mg per day.

For insomnia, clinicians typically use 25–100 mg at bedtime as off‑label practice.

Condition‑Specific Dosing Adjustments

How should dosing change for different patients?

For depression, titrate gradually over two to four weeks and continue treatment for a minimum of six months after remission.

Elderly

What precautions apply to seniors?

Start low—often 50 mg at bedtime for insomnia—and monitor for orthostatic hypotension and hyponatraemia risk.

Hepatic/Renal Impairment

How to dose in organ impairment?

Lower initial doses and slower titration are advised to avoid accumulation in hepatic or renal impairment.

Pediatrics

Can children use trazodone?

Use in children is not routinely recommended; safety and efficacy are not established and major agencies do not approve pediatric depression indications for trazodone.

Practical tip: consider extended‑release formulations when adherence or tolerability is a concern and reconcile choices with DIN and provincial formulary coverage.

Safety Protocols

Contraindications (Canadian Advisories)

Who should not take trazodone?

Absolute contraindications include known hypersensitivity to trazodone, recent myocardial infarction, and acute intoxication with alcohol or other CNS depressants.

Relative cautions include cardiac disease with QT risk, seizure disorder, bipolar disorder (risk of mania), angle‑closure glaucoma, and severe hepatic or renal impairment.

Adverse Effects (Post‑Market Reports)

What adverse effects should patients and pharmacists watch for?

Common adverse effects are sedation, dizziness and orthostatic hypotension, dry mouth, nausea, blurred vision and constipation.

Rare but serious events reported include priapism (a medical emergency), serotonin syndrome when combined with other serotonergic agents, hyponatraemia due to SIADH, and arrhythmias.

Monitor elderly patients closely for falls and report adverse events to Health Canada as appropriate.

Pharmacists should document counselling and follow‑up in the patient record.

Interaction Mapping

Food Interactions Common In Canadian Diet

Will food change how trazodone works?

No major food‑drug interactions require avoidance, but heavy alcohol intake potentiates sedation and respiratory depression and should be discouraged.

High‑fat meals may modestly affect absorption of immediate‑release formulations.

Drug Combinations Flagged By Health Canada

Which drugs raise concern when taken with trazodone?

Combining trazodone with other serotonergic drugs such as SSRIs, SNRIs or triptans raises serotonin syndrome risk and requires caution.

Potent CYP inhibitors or inducers can alter trazodone levels and may require dose adjustment.

Additive CNS depression occurs with benzodiazepines, opioids and antihistamines and increases fall and respiratory risk.

Concurrent QT‑prolonging medications merit ECG consideration in at‑risk patients.

Pharmacists should check provincial drug interaction databases and counsel patients on over‑the‑counter sleep aids, St. John’s wort and opioid co‑use.

Patient Experience Analysis

Canadian Survey Data

Do patients find trazodone helpful?

Surveys and clinic audits report improved sleep continuity at low doses and mood benefit at antidepressant doses.

Complaints commonly include daytime sedation, dizziness and sexual dysfunction, and older patients report orthostatic symptoms more frequently.

Forum & Community Pharmacy Trends

What do community pharmacies hear at the counter?

Pharmacies and online forums show switching between generic manufacturers, such as TEVA‑TRAZODONE or APO‑TRAZODONE, can create adherence concerns for some patients.

Patients often prefer clear bilingual (EN/FR) labelling and plain counselling about expected sedation and fall precautions.

Cost and access to CBT‑I or specialist sleep services, plus provincial coverage through programs like ODB, BC PharmaCare or RAMQ, shape acceptance and long‑term use.

Pharmacists should integrate patient‑reported outcomes with objective safety monitoring and document follow‑up.

Distribution & Pricing Landscape

National Pharmacy Chains

Where can Canadians get trazodone locally?

Major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs commonly stock trazodone generics from suppliers like TEVA, APO and Pro Doc.

Availability of specific brands such as Desyrel or particular extended‑release products varies by province and supplier, so pharmacists must verify DIN and package size for substitution.

Online Pharmacy Availability & Provincial Restrictions

Can trazodone be ordered online?

Licensed Canadian online pharmacies dispense trazodone with a valid prescription, and provincial rules on e‑prescribing and couriering prescriptions vary.

Some provinces require pharmacist verification for new starts.

Note: in our online pharmacy, trazodone is available without a prescription, with discreet delivery to Canada in 5–14 days.

Cross‑Border US Comparisons

Is it cheaper to order from the United States?

Cross‑border price differentials exist and some Canadians seek US pharmacies for lower per‑tablet costs, but importation limits and the lack of a Canadian DIN make this approach complex.

Provincial formularies such as ODB, BC PharmaCare and RAMQ can offer coverage for eligible patients and may be a safer route for access and reimbursement.

Alternative Options

Comparison Of DIN‑Approved Alternatives

What else can treat depression with sedating effects?

Common alternatives in Canada include SSRIs such as sertraline, escitalopram and fluoxetine for depression, and sedating options like mirtazapine or doxepin for sleep.

Select agents by indication, comorbidity and provincial formulary (DIN) status.

Pros And Cons Checklist

How does trazodone stack up?

• Pros: Sedating at low dose, low abuse potential, multiple generic suppliers that support availability.
• Cons: Orthostatic hypotension, rare priapism, limited long‑term insomnia RCT data.

SSRIs have robust depression efficacy but can cause sexual side effects and may be activating for insomnia.

Mirtazapine provides strong sedation and appetite stimulation but can lead to weight gain.

Choose treatments aligned with patient goals, coexisting conditions and provincial drug benefit coverage.

Regulatory Status

Health Canada Approval Process

How was trazodone approved?

Trazodone products are approved via New Drug Submissions or reliance on foreign dossiers, and Health Canada classifies them as prescription‑only with product monographs detailing dosing and safety.

Manufacturers must maintain post‑market safety reporting to Health Canada.

DIN And Bilingual Labelling Rules

What should pharmacists check at dispensing?

Canadian products require a Drug Identification Number (DIN) and bilingual English/French labelling in most retail contexts.

Provincial substitution is allowed per local rules if therapeutic equivalence is established and proper records are kept.

Pharmacists should verify current monographs and provincial formulary listings for up‑to‑date DINs and reimbursement status.

Consolidated FAQ

Is trazodone approved in Canada?

Yes; trazodone is prescribed for major depressive disorder and products are prescription‑only, with names such as Desyrel and several international brands in circulation.

Can I use trazodone for sleep?

Low‑dose use at 25–100 mg nightly is common off‑label and supported by short‑term evidence for sleep continuity, but long‑term randomized data for insomnia are limited.

Are generics interchangeable?

Generics that share a Canadian DIN and established therapeutic equivalence are generally interchangeable, and common manufacturers include TEVA and APO.

What should seniors watch for?

Seniors should watch for fall risk, orthostatic hypotension and hyponatraemia; start low, monitor electrolytes and orthostatic vitals, and arrange early follow‑up.

Visual Guide

What visuals help patients and clinicians at a glance?

Recommended infographics include a dosage ladder covering 25 mg up to 600 mg inpatient ceiling with IR versus ER notes, a provincial coverage map displaying likely reimbursement through ODB, BC PharmaCare and RAMQ, and a purchase channels flowchart from prescription to community pharmacy or licensed online pharmacy and delivery options.

Key icons should differentiate brand versus generic, flag red‑alert safety issues such as priapism, hyponatraemia and falls, and show a bilingual label mock‑up with DIN placement.

Design guidance: use large fonts and clear icons for older adults, include QR links to product monographs and provincial formularies, and add a pharmacist counselling checklist.

Storage & Transport

Canadian Household Guidelines

How should trazodone be stored at home?

Store trazodone at room temperature between 15–30°C (59–86°F) in the original container and protect tablets from moisture and light.

Keep the medicine out of reach of children and pets and return expired or unused medication to community pharmacy take‑back programs or municipal hazardous waste schemes.

Cold‑Chain Storage Where Applicable

Does trazodone need refrigeration?

Trazodone formulations do not require cold‑chain storage.

When mailing prescriptions, avoid prolonged exposure to extreme heat such as leaving packages in a car trunk during summer to protect tablet integrity, and ensure courier packaging shields blister packs.

Pharmacists should confirm storage counselling at dispensing and provide bilingual written instructions to support comprehension.

Guidelines For Proper Use

Advice From Canadian Pharmacists

What should pharmacists do at dispensing?

Verify indication, reconcile current medications for interactions, counsel on starting dose and titration, and advise on orthostatic precautions and avoiding alcohol and cannabis while sedated.

Recommend baseline blood pressure and electrolytes for elderly or symptomatic patients.

Document counselling and arrange follow‑up within one to two weeks of initiation or after dose changes.

Provincial Health Authority Guidance

How to align practice with provincial rules?

Follow provincial formularies and substitution policies for reimbursement and therapeutic interchange.

Use Health Canada monographs for contraindications and adverse event reporting pathways.

For off‑label insomnia use, consider referral to CBT‑I services and document informed consent when appropriate.

Practitioners should align care with up‑to‑date monographs, provincial guidance and patient‑centred monitoring.

Delivery Across Canada (English)

Final Practical Notes

What to review before starting trazodone?

Check the product monograph and DIN when dispensing and reconcile the full medication list for serotonergic agents, opioids and CYP inhibitors or inducers.

Advise patients about common side effects and red flags such as prolonged erection, severe dizziness on standing, confusion or signs of hyponatraemia.

Ensure seniors receive orthostatic checks and early lab follow‑up where clinically indicated.

Document counselling and plan follow‑up contact within one to two weeks of a new start or dose change to assess tolerability and response.

References And Where To Learn More

Which sources support these recommendations?

Information in this article is drawn from product monographs, pharmacology classifications (ATC N06AX05), registration summaries and pharmacopeia listings for trazodone.

For dosing, contraindications and storage, consult the trazodone product monograph and provincial formularies for DIN details and reimbursement rules.